Serge J. W. Walvoort

Serge J. W. Walvoort

Auto-generated profile, based on publicly available information

Serge J. W. Walvoort

Center of Excellence for Korsakoff and Alcohol-Related Cognitive Disorders, Vincent van Gogh Institute for Psychiatry, 5800 Venray, The Netherlands

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2019 in Drug and Alcohol Review
Verified
Journal Article
Open access
PDF file
CBCarolien Bruijnen
Carolien Bruijnen
BDBoukje Dijkstra
Boukje Dijkstra
SWSerge J. W. Walvoort
Serge J. W. Walvoort
Wiebren MarkusWiebren Markus
Wiebren Markus
JVJoanne VanDerNagel
Joanne VanDerNagel
CJCornelis A. J. DE Jong
Cornelis A. J. DE Jong
Introduction and Aims: Cognitive impairments in substance use disorder predict treatment outcome and are assumed to differ between substances. They often go undetected, thus the current study focuses on the prevalence of and differences in cognitive functioning across substances by means of a cognitive screen at the early stage of addiction treatment.Design and Methods: The Montreal Cognitive Assessment was administered to outpatients seeking treatment for substance use disorder. Patient characteristics (age, years of regular use, polysubstance use, severity of dependence/abuse, depression, anxiety and stress) were also taken into account.Results: A total of 656 patients were included (n = 391 used alcohol, n = 123 used cannabis, n = 100 used stimulants and n = 26 used opioids). The prevalence of cognitive impairments was 31%. Patients using alcohol had a lower total‐ and memory domain score than those using cannabis. Patients using opioids scored lower on visuospatial abilities than those using cannabis or stimulants. Younger patients scored higher than older patients. No effect was found for the other investigated characteristics.Discussion and Conclusions: Given the high prevalence of cognitive impairments, standard screening at an early stage of treatment is important to determine the course of treatment and maximise treatment outcome. Caution is needed in interpreting results about opioids due to an underrepresentation of this patient group, and more research is needed on the effect of age on Montreal Cognitive Assessment performance.

9 April 2020 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Open access
CBCarolien Bruijnen
Carolien Bruijnen
BDBoukje Dijkstra
Boukje Dijkstra
SWSerge J. W. Walvoort
Serge J. W. Walvoort
MBManon J. J. Budy
Manon J. J. Budy
HBHarmen Beurmanjer
Harmen Beurmanjer
Roy P. C. KesselsRoy P. C. Kessels
Roy P. C. Kessels
Objectives: The Montreal Cognitive Assessment (MoCA) is a cognitive screen, available in three alternate versions. Aims of the current study were to examine the effects of age, education and intelligence on MoCA performance and to determine the alternate-form equivalence and test–retest reliability of the MoCA, in a group of healthy participants. Method: In 210 participants, two MoCA versions and an estimator for premorbid intelligence were administered at two time points. Results: Age, education and estimated premorbid intelligence correlated significantly with the total score (MoCA-TS) and the Memory Index Score (MoCA-MIS). Systematic differences between MoCA version 7.1 and alternate versions 7.2 and 7.3 were only found for the items animal naming, abstract reasoning and sentence repetition. Test–retest reliability of the MoCA-TS was good between 7.1 and 7.2 (ICC: 0.64) and excellent between 7.1 and 7.3 (ICC: 0.82). For the MoCA-MIS, coefficients were poor (ICC: 0.32) to fair (ICC: 0.48), respectively. Conclusion: Adequate norms are needed that take the effects of age, education and intelligence on MoCA performance into account. All three MoCA versions are largely equivalent based on MoCA-TS and the test–retest reliabilities show that this score is suitable to monitor cognitive change over time. Comparisons of the domain-specific scores should be interpreted with caution.

1 July 2016 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
SWSerge Jw Walvoort
Serge Jw Walvoort
PHPaul T van der Heijden
Paul T van der Heijden
RKRoy Pc Kessels
Roy Pc Kessels
JEJos Im Egger
Jos Im Egger
Aim: Impaired illness insight may hamper treatment outcome in patients with alcohol-related cognitive deficits. In this study, a short questionnaire for the assessment of illness insight (eg, the Q8) was investigated in patients with Korsakoff’s syndrome (KS) and in alcohol use disorder (AUD) patients with mild neurocognitive deficits. Methods: First, reliability coefficients were computed and internal structure was investigated. Then, comparisons were made between patients with KS and patients with AUD. Furthermore, correlations with the Dysexecutive Questionnaire (DEX) were investigated. Finally, Q8 total scores were correlated with neuropsychological tests for processing speed, memory, and executive function. Results: Internal consistency of the Q8 was acceptable (ie, Cronbach’s α =0.73). The Q8 items represent one factor, and scores differ significantly between AUD and KS patients. The Q8 total score, related to the DEX discrepancy score and scores on neuropsychological tests as was hypothesized, indicates that a higher degree of illness insight is associated with a higher level of cognitive functioning. Conclusion: The Q8 is a short, valid, and easy-to-administer questionnaire to reliably assess illness insight in patients with moderate-to-severe alcohol-related cognitive dysfunction.

1 November 2016 in Psychiatry Research
Verified
Journal Article
Closed access
SWSerge J.W. Walvoort
Serge J.W. Walvoort
PHPaul T. van der Heijden
Paul T. van der Heijden
AWArie J. Wester
Arie J. Wester
RKRoy P.C. Kessels
Roy P.C. Kessels
JEJos I.M. Egger
Jos I.M. Egger

22 October 2020 in Alcohol and Alcoholism
Verified
Journal Article
Open access
PDF file
CBCarolien Bruijnen
Carolien Bruijnen
SWS J W Walvoort
S J W Walvoort
BDBoukje Dijkstra
Boukje Dijkstra
CJC A J de Jong
C A J de Jong
Roy P. C. KesselsRoy P. C. Kessels
Roy P. C. Kessels
Aims: In patients with a history of chronic alcohol abuse, neurocognitive disorders (NCD) are not uncommon. The current study aimed to explore the course of cognitive performance, as measured by the Montreal Cognitive Assessment (MoCA), and everyday cognitive functioning, as measured by the Patient Competency Rating Scale (PCRS), in a large group of patients with alcohol use disorder (AUD) admitted to the Center of Excellence for Korsakov and Alcohol-related Cognitive Impairments. Methods: A multiple time-series design was used, in which the MoCA was administered at three time points of assessment, and the PCRS was completed by both the patient and a clinician at two time points, all during clinical treatment. Results: A total of 524 patients were included, 71 of whom were diagnosed with AUD only, 284 with AUD and mild NCD (ARCI) and 169 with AUD, major NCD and fulfilling criteria for Korsakoff’s syndrome (KS). Conclusions: Cognitive performance improved for all three groups during treatment, sustained abstinence and recovery from AUD. A low memory performance on the MoCA without improvement over time was predictive for KS, while improvement on this domain did not differentiate between AUD and ARCI. Changes in overall cognitive performance and orientation in patients with KS were positively related to changes in everyday cognitive functioning.

2 October 2017 in Neuropsychological Rehabilitation
Verified
Journal Article
Open access
YRYvonne C. M. Rensen
Yvonne C. M. Rensen
JEJos I.M. Egger
Jos I.M. Egger
JWJosette Westhoff
Josette Westhoff
SWSerge J. W. Walvoort
Serge J. W. Walvoort
Roy P. C. KesselsRoy P. C. Kessels
Roy P. C. Kessels
Errorless learning has proven to be an effective method for (re)learning tasks in several patient groups with amnesia. However, so far only a handful of studies have examined the effects of errorless learning in patients with Korsakoff's syndrome. The aims of this feasibility study were to (a) examine the effects of errorless learning training on (re)learning tasks in a patient with Korsakoff's syndrome, (b) examine the effects of the nature of the training on the execution of the tasks, and (c) examine characteristics that may mediate learning outcome. Professional caregivers, who were trained in errorless learning principles, taught 51 patients with Korsakoff's syndrome two everyday tasks. Significant improvements in the performance were found after an errorless intervention for different types of trained tasks (activities of daily living, chores, mobility, housekeeping). Moreover, the results of this study suggest that all patients, despite of age, educational level, or level of cognitive functioning, may benefit from errorless learning. The results showed that, despite severe amnesia, patients with Korsakoff's syndrome have the potential to (re)learn everyday skills. Errorless learning might be beneficial for memory rehabilitation in patients with Korsakoff's syndrome in clinical practice. The results of this study are clinically relevant, as successfully learning tasks using errorless learning principles might improve autonomy and independence in the daily lives of patients with Korsakoff's syndrome.